Chitose Laboratory Corp.

Chitose Laboratory, founded in 2002 in Kanagawa, Japan, belongs to the Chitose Group and is a biotechnology company that aims to build a sustainable society through microorganism cultivation and cell engineering. In the world, the need for regenerative medicine or unmet medical (illnesses for which no cure has been found) is increasing every day. Chitose is aiming to speed up and reduce costs of the world's antibiotics manufacturing process through our unique and in-house developed CHO host cells "CHO-MK" cells to contribute to global healthcare. As a leader in the host cell market, Our CHO-Mk host cells can boast the world's highest production efficiency of antibody drugs. ● Through collaboration or consigned development with domestic and international pharmaceutical companies, we continue to produce new cell lines. ● As a member of the Manufacturing Technology Association of Biologics (MAB, AMED project), we are in charge of constructing the cell banks. Our technologies: -Technology to create diversity in a uniform cell pool and develop cells with several outstanding characteristics -Technology to screen for cells with desired characteristics from various cell pools -Technology to establish immortalized cell lines from primary tissue culture -Technology to develop test methods to comply with regulations for drug application